Clinical Trials Browser

Completed × anlotinib × 90 days × Clear all

NCT04660097 2026-04-08

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma

NCT04877821 2026-04-02

NeoSACT

Phase 2 Completed

Triple Negative Breast Neoplasms